Who
Leila Alland
Director
Company insider
Files Form 4 as: Director, Abeona Therapeutics; Chief Medical Officer, PMV Pharmaceuticals.
In numbers
- Trades disclosed
- 47
- Buys
- 1
- Sells
- 11
- Bought
- $52K
- Sold
- $1.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 7 Apr 2021
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $65K11,000 at $5.92 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $65K11,000 at $5.92 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $92K18,065 at $5.09 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $92K18,065 at $5.09 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 31 Jan 2025filed 3 Feb 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —36,101 at $0.00 | filing |
| 26 Aug 2024filed 27 Aug 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,797 at $0.00 | filing |
| 8 Jul 2024filed 9 Jul 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —23,611 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Bought | $52K11,000 at $4.71 | filing |
| 27 Sep 2023filed 29 Sep 2023 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $28K7,246 at $3.90 | filing |
| 15 Sep 2023filed 18 Sep 2023 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $42K6,291 at $6.62 | filing |
| 14 Jun 2023filed 16 Jun 2023 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | $271K58,689 at $4.62 | filing |
| 12 May 2023filed 15 May 2023 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 26 Sep 2022filed 28 Sep 2022 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —13,400 at $0.00 | filing |
| 9 Sep 2022filed 13 Sep 2022 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —52,200 at $0.00 | filing |
| 10 Feb 2022filed 28 Feb 2022 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,400 at $0.00 | filing |
| 9 Sep 2021filed 10 Sep 2021 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —100 at $0.00 | filing |
| 9 Sep 2021filed 10 Sep 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $390100 at $3.90 | filing |
| 9 Sep 2021filed 10 Sep 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $3,025100 at $30.25 | filing |
News
No headline names them, or the companies they trade most, lately.